Katherine C. Rappazzo, MD
Resident, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Jennifer R. Green, MD
Assistant Professor of Medicine,
Director of the Vanderbilt Hemophilia/ Hemostasis Treatment Clinic,
Vanderbilt University Medical Center, Nashville, Tennessee
In the treatment of acute venous thromboembolism (VTE) associated with an underlying malignancy, direct oral anticoagulants (DOACs) are now considered acceptable for some patient populations. National Comprehensive Cancer Network Guidelines indicate that low molecular weight heparin (LMWH) is an appropriate anticoagulant for the first 6 months in patients with proximal deep vein thrombosis or pulmonary embolism.
... to read the full story